CaIPF19998 reduces drug susceptibility by enhancing the ability of biofilm formation and regulating redox homeostasis in candida albicans

Current Microbiology

Volumn 67, Issue 3, 2013, Pages 322-326

  Sun, Xuanrong ^a   Lu, Hui ^a   Jiang, Yuanying ^a   Cao, Yingying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; REACTIVE OXYGEN METABOLITE; TERBINAFINE;

ALD5 GENE; ANTIFUNGAL RESISTANCE; ARTICLE; BIOFILM; CAIPF19998 GENE; CANDIDA ALBICANS; CELL ASSAY; CELL LEVEL; CIT1 GENE; CONTROLLED STUDY; DELETION MUTANT; FUNGAL GENE; FUNGAL STRAIN; GENE; GENE OVEREXPRESSION; HOMEOSTASIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PIL1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRX1 GENE; TSA1 GENE; UPREGULATION;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENE DELETION; HOMEOSTASIS; MICROBIAL SENSITIVITY TESTS; OXIDATION-REDUCTION;

CANDIDA; CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 84881102324     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-013-0366-x     Document Type: Article

References (25)

1. Anaissie EJ et al (1998) Predictors of adverse outcome in cancer patients with candidemia. Am J Med 104(3):238-245
2. Bachmann SP, Patterson TF, Lopez-Ribot JL (2002) In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 40(6):2228-2230
3. Care RS et al (1999) The MET3 promoter: a new tool for Candida albicans molecular genetics. Mol Microbiol 34(4):792-798
4. Chandra J et al (2001) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80(3):903-908
5. Cocuaud C et al (2005) Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56(3):507-512
6. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418):1318-1322
7. Davey ME, O'Toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64(4):847-867
8. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82(1):47-95
9. Espinel-Ingroff A, Rodriguez-Tudela JL, Martinez-Suarez JV (1995) Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J Clin Microbiol 33(12):3154-3158
10. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134(3):717-728
11. Gonzalez-Parraga P, Hernandez JA, Arguelles JC (2003) Role of antioxidant enzymatic defences against oxidative stress H(2)O(2) and the acquisition of oxidative tolerance in Candida albicans. Yeast 20(14):1161-1169
12. Ikner A, Shiozaki K (2005) Yeast signaling pathways in the oxidative stress response. Mutat Res 569(1-2):13-27
13. Ivarsson R et al (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54(7):2132-2142
14. Jamieson DJ (1998) Oxidative stress responses of the yeast Saccharomyces cerevisiae. Yeast 14(16):1511-1527
15. Kobayashi D et al (2002) Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46(10):3113-3117
16. Kuhn DM et al (2002) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70(2):878-888
17. Kuhn DM et al (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46(6):1773-1780
18. Nguyen MH et al (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155(22):2429-2435
19. Nicastri E et al (2001) Catheter-related bloodstream infections in HIV-infected patients. Ann N Y Acad Sci 946:274-290
20. O'Toole G, Kaplan HB, Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54:49-79
21. Phillips AJ, Sudbery I, Ramsdale M (2003) Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc Natl Acad Sci USA 100(24):14327-14332
22. Potera C (1999) Forging a link between biofilms and disease. Science 283(5409):1837-1839
23. Ramage G et al (2001) Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18(4):163-170
24. Wang Y et al (2006) Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med 40(7):1201-1209
25. Wheeler GL, Grant CM (2004) Regulation of redox homeostasis in the yeast Saccharomyces cerevisiae. Physiol Plant 120(1):12-20